+49% CAGR to Be Achieved by Biosimilars Market According to Market Research, Opportunity Analysis and Global Forecast 2018-2023
A biosimilar is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval. The global market for biosimilars is projected to grow at a significant rate in the coming few years, owing to the low cost of these...
View full press release